Karyopharm Therapeutics
KPTI
$1.10
Share price
3.77%
Change (1 day)
-71.43%
Change (1 year)
Categories
EPS for Karyopharm Therapeutics (KPTI)
EPS in 2023 (TTM): -$1.32
According to Karyopharm Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.32. In 2022 the company made an earnings per share (EPS) of -$2.03 a decrease over its 2021 EPS that were of -$1.66.
EPS history for Karyopharm Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.32 | -34.98% |
| 2022 | -$2.03 | 22.29% |
| 2021 | -$1.66 | -39.19% |
| 2020 | -$2.73 | -15.48% |
| 2019 | -$3.23 | 3.19% |
| 2018 | -$3.13 | 11.79% |
| 2017 | -$2.80 | -4.44% |
| 2016 | -$2.93 | -11.75% |
| 2015 | -$3.32 | 37.76% |
| 2014 | -$2.41 | -74.5% |
| 2013 | -$9.45 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $2.97 | -325.17% | 🇺🇸 USA |
 Merck MRK | $1.82 | -238.01% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -400.76% | 🇺🇸 USA |
 Exelixis EXEL | $0.28 | -121.46% | 🇺🇸 USA |